P
ZNTL icon

Pfizer’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Pfizer’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Hold
953,834
– – 2.26% 9
2026
Q1 		$2M Hold
953,834
– – 0.84% 12
2025
Q4 		$1.29M Hold
953,834
– – 0.54% 13
2025
Q3 		$1.44M Hold
953,834
– – 0.33% 14
2025
Q2 		$1.11M Hold
953,834
– – 0.19% 15
2025
Q1 		$1.52M Hold
953,834
– – 0.3% 15
2024
Q4 		$2.89M Buy
+953,834
New +$3.13M 0.11% 16

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Pfizer's ZNTL Position: Q2 2026 in Review

Pfizer held its Zentalis Pharmaceuticals (ZNTL) position steady in Q2 2026 at 953,834 shares worth $3.85M. The position accounts for 2.26% of the portfolio, ranked #9.

Pfizer first reported a position in ZNTL in Q4 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

  • Pfizer held 953,834 shares of Zentalis Pharmaceuticals worth $3.85M as of Q2 2026.
  • Pfizer left its Zentalis Pharmaceuticals share count unchanged in Q2 2026.
  • Zentalis Pharmaceuticals made up 2.26% of Pfizer's portfolio in Q2 2026, its #9 holding.
  • Pfizer first reported a position in Zentalis Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.